These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Implantable cardioverter defibrillators. Prophylactic use: an evidence-based analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2005; 5(14):1-74. PubMed ID: 23074465 [TBL] [Abstract][Full Text] [Related]
9. Sacubitril/Valsartan and Sudden Cardiac Death According to Implantable Cardioverter-Defibrillator Use and Heart Failure Cause: A PARADIGM-HF Analysis. Rohde LE; Chatterjee NA; Vaduganathan M; Claggett B; Packer M; Desai AS; Zile M; Rouleau J; Swedberg K; Lefkowitz M; Shi V; McMurray JJV; Solomon SD JACC Heart Fail; 2020 Oct; 8(10):844-855. PubMed ID: 32919916 [TBL] [Abstract][Full Text] [Related]
19. Prevention of sudden death in heart failure with reduced ejection fraction: do we still need an implantable cardioverter-defibrillator for primary prevention? Abdelhamid M; Rosano G; Metra M; Adamopoulos S; Böhm M; Chioncel O; Filippatos G; Jankowska EA; Lopatin Y; Lund L; Milicic D; Moura B; Ben Gal T; Ristic A; Rakisheva A; Savarese G; Mullens W; Piepoli M; Bayes-Genis A; Thum T; Anker SD; Seferovic P; Coats AJS Eur J Heart Fail; 2022 Sep; 24(9):1460-1466. PubMed ID: 35753058 [TBL] [Abstract][Full Text] [Related]
20. Mortality among ischemic and nonischemic heart failure patients with a primary implantable cardioverter-defibrillator. Yang PS; Kang Y; Bae HJ; Sung JH; Park HD; Joung B J Arrhythm; 2021 Dec; 37(6):1537-1545. PubMed ID: 34887959 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]